PROVENANCE BIOPHARMACEUTICALS

Provenance Biopharmaceuticals Corp. is a biotechnology company formed to create novel immune therapeutics to treat cancers and other diseases. Provenance is a leader in immunocytokine technology, a class of drugs designed to treat cancer by harnessing both the innate and adaptive immune system to eradicate tumor cells and permanently guard against their recurrence Provenance was founded in 2008 to continue the development of "immunocytokines" an antibody-cytokine fusion technology pioneered by Provenance founder, Dr. Stephen Gillies in the early 1990s.

Also known as: Provenance Biopharmaceuticals Corp

Primary location: Carlisle United States